Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Revenue (2016 - 2025)

Avanos Medical's Revenue history spans 11 years, with the latest figure at $170.4 million for Q3 2024.

  • For Q3 2024, Revenue fell 0.53% year-over-year to $170.4 million; the TTM value through Dec 2024 reached $508.2 million, down 24.52%, while the annual FY2023 figure was $673.3 million, 1.58% down from the prior year.
  • Revenue for Q3 2024 was $170.4 million at Avanos Medical, down from $171.7 million in the prior quarter.
  • Across five years, Revenue topped out at $197.4 million in Q1 2022 and bottomed at $35.8 million in Q4 2021.
  • The 5-year median for Revenue is $171.7 million (2024), against an average of $166.7 million.
  • The largest annual shift saw Revenue plummeted 80.65% in 2021 before it skyrocketed 300.84% in 2022.
  • A 5-year view of Revenue shows it stood at $185.0 million in 2020, then tumbled by 80.65% to $35.8 million in 2021, then surged by 300.84% to $143.5 million in 2022, then increased by 20.77% to $173.3 million in 2023, then decreased by 1.67% to $170.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Revenue are $170.4 million (Q3 2024), $171.7 million (Q2 2024), and $166.1 million (Q1 2024).